Literature DB >> 24777616

Damage Control Resuscitation In Trauma.

H M A Kaafarani1, G C Velmahos2.   

Abstract

INTRODUCTION: Most preventable trauma deaths are due to uncontrolled hemorrhage.
METHODS: In this article, we briefly describe the pathophysiology of the classical triad of death in trauma, namely, acidosis, hypothermia, and coagulopathy, and then suggest damage control resuscitation strategies to prevent and/or mitigate the effects of each in the bleeding patient.
RESULTS: Damage control resuscitation strategies include body rewarming, restrictive fluid administration, permissive hypotension, balanced blood product administration, and the implementation of massive transfusion protocols.
CONCLUSION: Resuscitating and correcting the coagulopathy of the exsanguinating trauma patient is essential to improve chances of survival. © The Finnish Surgical Society 2014.

Entities:  

Keywords:  Resuscitation; acidosis; blood component transfusion; consumption coagulopathy; hemorrhage; wounds and injury

Year:  2014        PMID: 24777616     DOI: 10.1177/1457496914524388

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  11 in total

Review 1.  Tranexamic acid: from trauma to routine perioperative use.

Authors:  Jeff Simmons; Robert A Sikorski; Jean-Francois Pittet
Journal:  Curr Opin Anaesthesiol       Date:  2015-04       Impact factor: 2.706

2.  A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial.

Authors:  Martin A Schreiber; Eric N Meier; Samuel A Tisherman; Jeffrey D Kerby; Craig D Newgard; Karen Brasel; Debra Egan; William Witham; Carolyn Williams; Mohamud Daya; Jeff Beeson; Belinda H McCully; Stephen Wheeler; Delores Kannas; Susanne May; Barbara McKnight; David B Hoyt
Journal:  J Trauma Acute Care Surg       Date:  2015-04       Impact factor: 3.313

3.  Elevated Admission Base Deficit Is Associated with a Complex Dynamic Network of Systemic Inflammation Which Drives Clinical Trajectories in Blunt Trauma Patients.

Authors:  Othman Abdul-Malak; Yoram Vodovotz; Akram Zaaqoq; Jesse Guardado; Khalid Almahmoud; Jinling Yin; Brian Zuckerbraun; Andrew B Peitzman; Jason Sperry; Timothy R Billiar; Rami A Namas
Journal:  Mediators Inflamm       Date:  2016-11-15       Impact factor: 4.711

Review 4.  Management of Pelvic Ring Injury Patients With Hemodynamic Instability.

Authors:  Meir Marmor; Ashraf N El Naga; Jordan Barker; Jacob Matz; Styliani Stergiadou; Theodore Miclau
Journal:  Front Surg       Date:  2020-11-12

5.  Benefits of Initial Limited Crystalloid Resuscitation in Severely Injured Trauma Patients at Emergency Department.

Authors:  Hao Wang; Richard D Robinson; Jessica Laureano Phillips; Alexander J Kirk; Therese M Duane; Johnbosco Umejiego; Melanie Stanzer; Mackenzie B Campbell-Furtick; Nestor R Zenarosa
Journal:  J Clin Med Res       Date:  2015-10-23

Review 6.  Damage control resuscitation: lessons learned.

Authors:  M Giannoudi; P Harwood
Journal:  Eur J Trauma Emerg Surg       Date:  2016-02-04       Impact factor: 3.693

7.  On table POCUS assessment for the IVC following abdominal packing: how I do it.

Authors:  Fikri M Abu-Zidan
Journal:  World J Emerg Surg       Date:  2016-08-05       Impact factor: 5.469

Review 8.  Assessing volume status and fluid responsiveness in the emergency department.

Authors:  David C Mackenzie; Vicki E Noble
Journal:  Clin Exp Emerg Med       Date:  2014-12-31

9.  Hypothermia in trauma victims at first arrival of ambulance personnel: an observational study with assessment of risk factors.

Authors:  Frédéric Lapostolle; James Couvreur; François Xavier Koch; Dominique Savary; Armelle Alhéritière; Michel Galinski; Jean-Luc Sebbah; Karim Tazarourte; Frédéric Adnet
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-04-24       Impact factor: 2.953

10.  Decision-making criteria for damage control surgery in Japan.

Authors:  Nao Urushibata; Kiyoshi Murata; Yasuhiro Otomo
Journal:  Sci Rep       Date:  2019-10-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.